Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1992The Journal of Clinical Endocrinology & Metabolism

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJohn D. McConnellAtrium Health Wake Forest BaptistJWJ D WilsonThe University of Texas Southwestern Medical CenterFGFredrick W. GeorgeThe University of Texas Southwestern Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McConnell et al. (1992) studied this question.

synapsesocial.com/papers/6a6fce1af44fa9f079dd4c7ahttps://doi.org/10.1210/jcem.74.3.1371291
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prostatic effects induced in dogs by chronic or acute oral administration of 5α‐reductase inhibitors1986 · 72 citations
  2. 2Effect of Finasteride, a 5<i>α</i>-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*1990 · 133 citations
  3. 3Dihydrotestosterone in prostatic hypertrophy1970 · 407 citations
  4. 4Concentration of Dihydrotestosterone and 3α-Androstanediol in Naturally Occurring and Androgen- Induced Prostatic Hyperplasia in the Dog1979 · 98 citations
  5. 5The Metabolic Basis of Inherited Disease.1988 · 7,802 citations